Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesGenetic & Molecular TestingCareSource Genetic Testing Prior Auth Policy Updat…
    Ask Trek AI about this page
    CurrentCareSourcePolicy N/A

    Genetic Testing and Counseling - Arkansas PASSE

    Customize your policy alerts

    Sign up for all CareSource policy alerts

    Know when CareSource releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs prior authorization, medical necessity review, and genetic counseling requirements for germline and somatic genetic testing for CareSource members in the Arkansas PASSE program.

    Policy Summary
    PayerCareSource
    PolicyGenetic Testing and Counseling - Arkansas PASSE
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJun 1, 2026
    Last ReviewMar 11, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization when required and ensure genetic counseling (including a 3‑generation family history) is provided for all germline genetic testing.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    genetic counselingpolicy requirement
    prior auth may be requiredauthorization note
    HLA excludedexplicit exclusion

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    MCG & AR statutes
    guidance sources

    Coverage and Medical Necessity Criteria

    Coverage criteria

    Covered when reviewed and approved per medical necessity determinations and MCG criteria as applicable:

    General coverage and review: Prior authorization may be required for genetic testing (somatic and germline) and CareSource will review for medical necessity using published MCG criteria when available and the Medical Necessity Determinations administrative policy.

    Proprietary panels require evidence-based documentation; individual tests may be requested separately if panels do not meet medical necessity.

    Germline testing counseling requirement: Genetic counseling is required for all germline genetic testing and must be provided by a healthcare professional with education and training in genetic issues relevant to the tests, and must enable informed decision making including a 3-generation family history and discussion of possible results and risks.

    Somatic testing does not require this genetic counseling.

    HLA typing exclusion: HLA typing is not part of the genetic testing policy and does not require preauthorization.
    Repeat germline testing: While most inherited genetic testing is only necessary once in a lifetime, repeat germline testing may be considered in extraordinary circumstances due to changes in technology with proper medical necessity documentation.

    HLA typing is explicitly excluded from this genetic testing policy and does not require preauthorization under the CareSource genetic testing policy.

    Proprietary multi-gene panels that do not meet medical necessity requirements per the Medical Necessity Determinations administrative policy may not be approved for coverage; in those cases, CareSource allows individual genetic tests to be requested and reviewed separately according to the Medical Necessity Determinations policy.

    Coding and Test Frequency

    No codes specifiedmixed
    No codes listed
    Repeat germline testing — inv-05
    Policy stanceRepeat germline testing is allowed only in extraordinary circumstances due to changes in technology and requires proper medical necessity documentation.
    Typical expectationMost inherited (germline) genetic testing is generally necessary only once in a lifetime.
    Documentation requiredProper medical necessity documentation must be submitted to justify repeat testing.
    Review processRequests for repeat germline testing will be considered by CareSource under medical necessity review.

    Provider Requirements and Prior Authorization

    Prior Authorization

    Prior Authorization Required

    Prior authorization may be required for genetic testing (both somatic and germline). Lack of required prior authorization when prior authorization is required for genetic testing may result in claim denial. Providers should verify prior authorization requirements before ordering tests.

    • Applies to somatic and germline genetic testing
    • Denial risk if required prior authorization not obtained
    Documentation Required

    Medical Necessity Review

    CareSource will review genetic testing requests for medical necessity using published MCG criteria when available and the Medical Necessity Determinations administrative policy. Proprietary panel testing requires evidence-based documentation per the Medical Necessity Determinations administrative policy; individual genetic tests may be requested separately for panels that do not meet medical necessity.

    Definitions

    Genetic Screening — inv-11
    DefinitionGenetic screening is the process of testing a population for a genetic disease to identify a subgroup of people who either have the disease or the potential to pass it to offspring.
    PurposeIdentify affected individuals or carriers within a broader population.
    ScopeApplied at a population level rather than targeted diagnostic testing for individuals.
    Genetic Testing — inv-12
    DefinitionGenetic testing is a medical test that identifies changes in genes, chromosomes, or proteins to confirm or rule out a suspected genetic condition, either hereditary or acquired.
    Use casesDiagnostic confirmation, carrier detection, or identification of acquired (somatic) changes relevant to treatment.

    Background and Rationale

    Advances in genetic technology have expanded the identification of genetic variants. Genetic testing can provide diagnostic information or actionable therapeutic guidance, and results may affect clinical management. Because of these implications, CareSource requires medical necessity review (using published MCG criteria when available) for somatic and germline testing and emphasizes appropriate genetic counseling where specified.

    Eligibility and Counseling Requirements

    Genetic counseling for germline testing must include collection and interpretation of a three-generation family history to inform whether a condition is heritable and to support individualized risk assessment, in addition to explaining the purpose of testing, possible results, and benefits/risks to enable informed decision making.

    Eligibility specifics for prior testing, ordering pathways, or additional documentation requirements are not specified in this policy.

    Tests Not Covered

    Proprietary panels that fail to meet medical necessity requirements per the Medical Necessity Determinations administrative policy are not covered; coverage may be provided for individual tests from the panel only if those tests independently meet medical necessity criteria and are supported by appropriate documentation.

    Policy Summary
    PayerCareSource
    PolicyGenetic Testing and Counseling - Arkansas PASSE
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJun 1, 2026
    Last ReviewMar 11, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization when required and ensure genetic counseling (including a 3‑generation family history) is provided for all germline genetic testing.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaCoding and Test FrequencyProvider Requirements and Prior AuthorizationDefinitionsBackground and RationaleEligibility and Counseling RequirementsTests Not Covered
    • MCG criteria and Medical Necessity Determinations policy guide reviews
    • Proprietary panels need evidence-based justification
    Documentation Required

    Genetic Counseling Requirement

    Genetic counseling is required for all germline genetic testing and must be provided by a healthcare professional with relevant education and training in genetic issues relevant to the tests under consideration. Counseling must enable informed decision-making by the member (purpose of testing, potential management implications, heritable nature with a 3‑generation family history, range of possible results, and potential benefits/risks such as psychological, social, and economic). Somatic genetic testing does not require the genetic counseling described above.

    • Required for all germline genetic testing
    • May be provided by appropriately trained healthcare professionals
    • Somatic testing exempt from this counseling requirement
    Note

    Provider Actions — Not Otherwise Specified

    Providers: The document does not specify additional provider action details beyond prior authorization and documentation requirements. Verify prior authorization and include evidence-based documentation and genetic counseling (for germline tests) where applicable to avoid denial.

    • Provider-specific actions beyond prior authorization are not specified in this policy
    • Obtain prior authorization when required and supply documentation to support medical necessity
    • Ensure genetic counseling is documented for germline testing
    Documentation Required

    Proprietary Panel Testing

    Proprietary panels: Evidence-based documentation per the Medical Necessity Determinations policy is required. If a panel does not meet medical necessity criteria, CareSource may request individual test justification or deny coverage.

    • Proprietary panel testing requires evidence-based support
    • Individual tests may be requested separately if panel fails medical necessity
    Note

    Scope and Repeat Testing

    HLA typing is outside the scope of this genetic testing policy and does not require prior authorization under this policy. Most inherited germline testing is typically performed once in a lifetime; repeat germline testing may be considered only in extraordinary circumstances with appropriate medical necessity documentation.

    • HLA typing not covered by this policy — no preauthorization required
    • Repeat germline testing allowed only with documented extraordinary justification
    Result typesMay detect gene, chromosomal, or protein changes that inform diagnosis or management.
    HLA Typing — inv-13
    DefinitionHuman Leukocyte Antigen (HLA) typing is a test used to match patients and donors for bone marrow or cord blood transplants.
    Policy noteHLA typing is not part of the genetic testing policy and does not require preauthorization.
    Clinical usePrimarily used for donor–recipient compatibility in transplant settings.
    Inherited Genetic Variant — inv-14
    DefinitionAn inherited genetic variant is a DNA sequence change passed from a parent to offspring (germline).
    ImplicationGermline variants can have lifelong implications and inform inherited disease risk and family counseling.
    Counseling requirementGenetic counseling is required for all germline testing and must include a 3-generation family history to inform heritable nature and risk assessment.
    Precision Medicine — inv-15
    DefinitionPrecision medicine is a field of medicine that selects pharmacotherapies based on the patient's genetics.
    ApplicationUses genetic information to guide therapy selection and optimize treatment effectiveness.
    Relation to testingPharmacogenomic results are a common precision medicine application.
    Somatic Gene Variant — inv-16
    DefinitionA somatic gene variant is a DNA sequence change that is not inherited from a parent but is acquired during a person's life.
    Clinical relevanceSomatic variants are often detected in tumors and can inform targeted therapies.
    Policy implicationSomatic genetic testing may require prior authorization and medical necessity review but does not require the germline-specific genetic counseling described in the policy.